iShares Nasdaq Biotechnology Index Fund ETF News

Many are calling the recent market activity similar to the great depression of the 1930’s. And clearly there are some comparisons. But what did not exist in the 1930’s was this level of QE.

Allred Capital Management LLC grew its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 94.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutiona

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) reached a new 52-week high on Friday . The company traded as high as $124.80 and last traded at $122.35, with a volume of 203334 shares changing hands. Th

Bailard Inc. lessened its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 10.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 16.) Abbott Laboratories (...

The Fed and government stimulus, especially with debt buying, has encouraged the bulls for a repeat performance in QQQ, SPY, and SMH.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) Bio-Rad Laboratories,...

Bank of New York Mellon Corp lessened its position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 3.0% in the fourth quarter, according to the company in its most recent disclosure with

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs April 14) Bio-Rad Laboratories, Inc...

Gilead Sciences (GILD) has ignited a ray of hope with its recently-released positive data on the role of remdesivir as a COVID-19 treatment.

Gilead Sciences (GILD) has ignited a ray of hope with its recently-released positive data on the role of remdesivir as a COVID-19 treatment.

Capital Investment Advisors LLC cut its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 4.2% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 10,373

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) Chembio...

Regional Banks are in focus today for a few reasons.